Sign the Statement
Sign Your Name to the Clinical Experts and Community Advocates' Statement
Thanks to advocacy by the oral health community, Medicare now provides coverage for oral and dental examination, diagnostic, and treatment services to eliminate infections that can impact the clinical success of many Medicare-covered medical services. This important progress brings Medicare closer to treating oral infection in the same manner the program treats infection everywhere else in the body.
Our work is not yet done, however. Medicare officials will soon be considering nominations to expand coverage to diabetes-associated retinopathy, diabetes-associated nephropathy, and hospital-acquired pneumonia, inclusive of sepsis risk reduction. To help this cause, please add your name to this Clinical Experts and Community Advocates' Statement. Thank you!

Clinical Experts and Community Advocates’ Statement on Medicare Coverage for Medically Necessary Oral and Dental Treatment
We, the undersigned physicians, dentists, nurses, dental hygienists, and other clinical leaders, commend the Centers for Medicare & Medicaid Services (CMS) for the progress it has made to close a longstanding gap in Medicare: the exclusion of oral and dental care vital to the success of covered medical treatment.
Although Section 1862(a)(12) of the Social Security Act excludes routine dental services from Medicare coverage, it does not and never has excluded coverage of oral and dental care that is required for a covered medical treatment to proceed and succeed. This important distinction was confirmed in 2020 when the Department of Health and Human Services (HHS) Office of General Counsel (OGC) validated that the Medicare statute does not exclude coverage for oral and dental care when it is inextricably linked to, and substantially related and integral to, the clinical success of Medicare-covered medical services.
CMS subsequently formalized this policy under 42 C.F.R. § 411.15(i) and extended medically necessary oral and dental coverage to exams, diagnostic, and treatment services to eliminate oral or dental infections that can impact the clinical success of a range of Medicare-covered medical services, including organ and stem cell transplantation, cardiac valve replacement, valvuloplasty procedures, head and neck cancer treatment, cancer chemotherapy, chimeric antigen receptor (CAR) T-cell therapy, high-dose bonemodifying agents, and dialysis for End Stage Renal Disease (ESRD). In each case, CMS recognized that untreated oral and dental infections undermine medical care, driving complications and increasing cost.
CMS’ action underscores that Medicare should not categorically exclude treatment of infection in one part of the body – the mouth – while covering treatment of microbial infection everywhere else in the body. Indeed, private insurers, transplant programs, and the Veterans Health Administration have long provided targeted oral and dental coverage for high-risk patients, and the lower hospitalization and emergency department utilization they routinely document can now finally be realized by Medicare.
That said, extensive clinical and fiscal evidence supports extending this same logic further. Specifically, we join in urging CMS to consider extending medically necessary coverage to Medicare beneficiaries at risk of diabetes-associated retinopathy, diabetes-associated nephropathy, or hospital-acquired pneumonia:
• Diabetes affects 15% of all Americans and nearly 30% of older adults at an annual cost exceeding $400 billion. Since treatment of periodontitis achieves clinically significant reductions in HbA1c, its provision is vital to protecting at-risk diabetic individuals from the loss of eyesight due to diabetes-associated retinopathy and kidney failure due to diabetes-associated nephropathy.
• Hospital-acquired pneumonia affects more than 300,000 U.S. patients, has an associated mortality of up to 30%, and costs more than $3 billion annually. HAP arises largely from aspiration of oral bacteria and is a leading source of sepsis, but its risk can be mitigated with dental clearance services prior to hospital admission as well as standardizing daily toothbrushing of hospitalized patients.
As a result, we recommend adding diabetes-associated retinopathy, diabetes-associated nephropathy, and hospital-acquired pneumonia, inclusive of sepsis risk reduction, to the conditions qualifying for medically necessary dental coverage. We also urge the Administration and Congress to continue building towards a Medicare program that treats oral infection in the same manner as it treats infection anywhere else in the body. The clinical evidence is compelling, the fiscal savings are substantial, and the beneficiaries who would directly benefit from this action – older adults with diabetes, kidney disease, and heightened pneumonia risk – cannot afford to wait.